Evidence-informed management of chronic low back pain with epidural steroid injections
Abstract
Editors' preface
The management of chronic low back pain (CLBP) has proven very challenging in North America, as evidenced by its mounting socioeconomic burden. Choosing amongst available nonsurgical therapies can be overwhelming for many stakeholders, including patients, health providers, policy makers, and third-party payers. Although all parties share a common goal and wish to use limited health-care resources to support interventions most likely to result in clinically meaningful improvements, there is often uncertainty about the most appropriate intervention for a particular patient. To help understand and evaluate the various commonly used nonsurgical approaches to chronic low back pain, the North American Spine Society has sponsored this special focus issue of The Spine Journal, titled Evidence-Informed Management of Chronic Low Back Pain Without Surgery. Articles in this special focus issue were contributed by leading spine practitioners and researchers, who were invited to summarize the best available evidence for a particular intervention and encouraged to make this information accessible to nonexperts. Each of the articles contains five sections (description, theory, evidence of efficacy, harms, and summary) with common subheadings to facilitate comparison across the 24 different interventions profiled in this special focus issue, blending narrative and systematic review methodology as deemed appropriate by the authors. It is hoped that articles in this special focus issue will be informative and aid in decision making for the many stakeholders evaluating nonsurgical interventions for CLBP.
Keywords: Low back pain, Lumbar pain, Corticosteroids, Epidural steroid injection, Therapeutic agents
To access this article, please choose from the options below
Authors acknowledge a financial relationship (MJD—grant research support from Genzyme Biosurgery; consultant for Stryker Interventional Pain, Kyphon, and AOI; speaker's bureau for Pfizer; stockholder for AOI [stock options not exercised]; and other support from Medtronic grant support of ACGME [accredited pain management fellowship program]. CWS—consultant for Stryker and Arthrocare and stockholder for Arthrocare), which may indirectly relate to the subject of this research.
PII: S1529-9430(07)00872-8
doi:10.1016/j.spinee.2007.09.009
© 2008 Elsevier Inc. All rights reserved.
